Therapeutic/Medical

WorldCare Clinical’s (WCC) strategic relationship with the Massachusetts General Hospital (MGH) Department of Radiology—one of the world’s preeminent medical institutions—is the foundation of our unique therapeutic model.

 

Our strategic relationship of more than 14 years allows us to provide our clinical trial sponsors with independent physician reader services by board-certified, sub-specialty trained radiologists. Because we have access to these radiologists in the MGH Clinical Trials Program, we can provide our sponsors with a wide array of therapeutic and medical expertise, and flexibility in handling large volumes of images for their trials.

 

In addition to MGH physician readers, WCC offers the in-house expertise of24 radiologists from ProScan Imaging, one of the most advanced operators of freestanding diagnostic imaging centers in the world. Depending on the specialized service requested by our sponsor, WCC will work directly with MGH or the University of Chicago Medical Center, with our in-house radiologists, or with radiologists of the sponsor’s choosing anywhere in the world. Our unparalleled image handling expertise and teleradiology network allows for the secure and efficient transfer of clean data worldwide within minutes.

 

Independent reading services require that all radiologists reading for a clinical trial must complete inter- and intra- variability training prior to any measurements.

 

Unique to WCC, our rigorous therapeutic model provides our sponsors with:

 

• The ability to manage various imaging volumes for imaging trials on demand, productively and efficiently, without additional fixed costs to our sponsors, which means studies are always completed on time and on budget.
• Sub-specialty radiologist expertise that ensures a low variability level between image reads, and thus the generation and submission of consistent data.
• Access to independent and in-house physician readers, depending on the sponsor’s needs.

 

Therapeutic Areas:

 

Oncology. WCC has a wealth of experience in managing imaging for oncology clinical trials. In fact, more than half of our business involves cancer states such as prostate, pancreatic, breast, lymphoma, colorectal, brain, liver, melanoma, ovarian, sarcoma, and renal cell.

 

Central nervous system. WCC has managed clinical trial imaging studies for a variety of central nervous systems diseases, including Alzheimer’s disease, epilepsy, multiple sclerosis, vascular dementia, and other neurodegenerative diseases and cerebrovascular disorders.

 

Musculoskeletal. MGH radiology staff includes physicians proficient in sports-related injuries, pain management, bone and muscle tumors, osteoporosis, and many other joint and spine diseases. WCC’s chief medical officer, Dr. Stephen Pomeranz, is recognized as one of the top MR musculoskeletal specialists.

 

Women’s health. MGH and WCC physicians are experienced in all women’s health modalities, including mammography, breast MRI, optical imaging, and digital tomosynthesis.

 

Cardiovascular. WCC’s clinical trial experience includes cardiac MRI and CT, cardiac contrast agents, and invasive and noninvasive vascular imaging in disease states such as myocardial infarction, congestive heart failure, peripheral vascular disease, and coronary artery disease, in addition to devices such as drug-eluting stents.

 

Metabolic. WCC has managed imaging for clinical trial studies involving glandular disorders such as obesity, muscular dystrophy, diabetes, hyperthyroidism, and Addison’s disease, among others.

 

For more information on these and other services please email us at info@wcclinical.com or call us at 1 (888) 816-4721.

 

 

< Back